GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Marketable Securities

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Marketable Securities : HK$0 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Zhongzhi Pharmaceutical Holdings's Marketable Securities for the quarter that ended in Dec. 2024 was HK$0 Mil.

Zhongzhi Pharmaceutical Holdings's annual Marketable Securities declined from Dec. 2022 (HK$16 Mil) to Dec. 2023 (HK$2 Mil) and declined from Dec. 2023 (HK$2 Mil) to Dec. 2024 (HK$0 Mil).


Zhongzhi Pharmaceutical Holdings Marketable Securities Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Marketable Securities Chart

Zhongzhi Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 10.77 16.40 2.49 -

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.40 7.78 2.49 - -

Zhongzhi Pharmaceutical Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Zhongzhi Pharmaceutical Holdings  (HKSE:03737) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Zhongzhi Pharmaceutical Holdings Marketable Securities Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongzhi Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN
Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations are divided into two segments, namely Pharmaceutical manufacturing, and Operation of chain pharmacies. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing, and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. It derives a majority of its revenue from the PRC.
Executives
Jiang Li Xia 2202 Interest of your spouse
Lai Zhi Tian 2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited 2101 Beneficial owner
Cheng Jin Le 2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited 2101 Beneficial owner
Novich Positioning Investment (cayman) Limited 2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership 2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines